Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

41
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
41
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

59
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
59
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

13
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
13
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.

Diabetes care·2026
Same author

Impact of Intrinsic Defects and Tungsten Doping on the Catalytic Properties of Two-Dimensional Cu<sub>2</sub>S.

ACS omega·2026
Same author

Artificial Intelligence for Blood Glucose Level Prediction in Type 1 Diabetes: Methods, Evaluation, and Emerging Advances.

Sensors (Basel, Switzerland)·2026
Same author

MGPP-DL: deep learning approach for material graph properties prediction.

Journal of molecular modeling·2026
Same author

Exploring the Use of Hybrid Closed-Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England Pilot.

Journal of diabetes research·2026
Same author

Physical Activity Integration in Blood Glucose Level Prediction: Different Levels of Data Fusion.

IEEE journal of biomedical and health informatics·2024

Related Experiment Video

Updated: Apr 28, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

8.8K

Personalised Blood Glucose Time Series Forecasting in Type 1 Diabetes: Deep Collaborative Adversarial Learning.

Heydar Khadem1, Hoda Nemat1, Jackie Elliott2,3

  • 1Department of Electronic and Electrical Engineering, University of Sheffield, Sheffield S5 7AU, UK.

Journal of Personalized Medicine
|April 27, 2026
PubMed
Summary

This study introduces collaborative augmented adversarial learning for improved blood glucose prediction in type 1 diabetes (T1D). The novel method enhances temporal awareness, leading to more accurate and clinically relevant glucose forecasts for personalized diabetes management.

Keywords:
artificial intelligenceblood glucose predictiondeep learningpersonalised diabetes managementtime series forecasting

Related Experiment Videos

Last Updated: Apr 28, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

8.8K

Area of Science:

  • Biomedical Engineering
  • Artificial Intelligence
  • Data Science

Background:

  • Blood glucose prediction (BGP) is crucial for type 1 diabetes (T1D) management and personalized medicine.
  • Glycaemic fluctuations in T1D present significant challenges for accurate time series forecasting (TSF).
  • Conventional adversarial learning methods have limitations in capturing long-term temporal dependencies for BGP.

Purpose of the Study:

  • To develop an advanced BGP technique addressing limitations in conventional adversarial learning.
  • To enhance temporal awareness and clinical relevance in blood glucose forecasting models.
  • To improve personalized diabetes management through more accurate glucose predictions.

Main Methods:

  • Introduced collaborative augmented adversarial learning to improve temporal awareness in BGP.
  • Incorporated collaborative interaction optimization to capture extended time dependencies.
  • Evaluated four learning systems (independent, adversarial, collaborative, adversarial collaborative) for 30-min and 60-min prediction horizons.

Main Results:

  • Collaboratively augmented learning frameworks demonstrated statistically significant superior performance.
  • The approach showed improvements in both clinical relevance and overall predictive performance.
  • Validated using the Ohio T1D datasets, confirming enhanced BGP accuracy.

Conclusions:

  • The proposed approach advances BGP accuracy and clinical reliability for T1D management.
  • It supports personalized medicine by improving subject-specific glucose forecasting from continuous glucose monitoring (CGM) data.
  • Opens new avenues for TSF in other complex domains.